Inventor · San Francisco, CA, US

Jeffrey Wu

14Patents

4h-index

49Co-inventors

56Inventor score

Filing activity: May 30, 2008 → Aug 18, 2022

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9718847B2	Heterocyclic compounds and uses thereof	Emerging Cross-Sectional Technologies	31	Active
US9938273B2	Compounds and methods for kinase modulation, and indications therefor	Chemistry; Metallurgy	15	Active
US10160747B2	Compounds and methods for kinase modulation, and indications therefor	Chemistry; Metallurgy	7	Active
US11479556B1	Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway	Chemistry; Metallurgy	4	Active
US10519177B2	Heterocyclic compounds and uses thereof	Emerging Cross-Sectional Technologies	3	Active
US10703757B2	Compounds and methods for CDK8 modulation and indications therefor	Chemistry; Metallurgy	3	Active
US11866442B2	Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway	Chemistry; Metallurgy	1	Active
US11446287B2	Compounds and methods for EP300 or CBP modulation and indications therefor	Chemistry; Metallurgy	1	Active
US9981977B2	Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst	Chemistry; Metallurgy	0	Active
US11679121B2	Morpholino oligonucleotides useful in cancer treatment	Human Necessities	0	Active
US8026362B2	Non-nucleoside reverse transcriptase inhibitors	Chemistry; Metallurgy	0	Active
US7947709B2	Non-nucleoside reverse transcriptase inhibitors	Chemistry; Metallurgy	0	Active
US10857174B2	Morpholino oligonucleotides useful in cancer treatment	Human Necessities	0	Active
US11976071B2	Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinases	Emerging Cross-Sectional Technologies	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.